Latest Plasmodium Stories
A team of scientists have for the first time developed a vaccine for malaria that has been found to be 100 percent effective in a small clinical trial. The vaccine, known as PfSPZ Vaccine, was developed by Sanaria Inc.
Human migrations—from the prehistoric epoch to the present day—have extended cultures across the globe.
Using faecal samples collected from wild chimpanzees, an international team of researchers from the Max Planck Institute for Evolutionary Anthropology in Leipzig and the Robert Koch Institute in Berlin has now investigated the effect of the animals’ age on malaria parasite detection rates.
Malaria-carrying mosquitos appear to be manipulated by the parasites they carry, but this manipulation may simply be part of the mosquitos' immune response, according to Penn State entomologists.
Mosquitoes infected with the malarial parasite Plasmodium falciparum are significantly more attracted to human odors than uninfected mosquitoes.
An international study, involving researchers from Griffith University's Eskitis Institute, has discovered a molecule which could form the basis of powerful new anti-malaria drugs.
Early diagnosis and treatment with antimalarial drugs (ACTs—artemisinin based combination treatments) has been linked to a reduction in malaria in the migrant population living on the Thai-Myanmar border, despite evidence of increasing resistance to ACTs in this location.
A novel tool exploits baker's yeast to expedite the development of new drugs to fight multiple tropical diseases, including malaria, schistosomiasis, and African sleeping sickness.
New research has revealed that immature malaria parasites are more resistant to treatment with key antimalarial drugs than older parasites, a finding that could lead to more effective treatments for a disease that kills one person every minute and is developing resistance to drugs at an alarming rate.
- A serpent whose bite was fabled to produce intense thirst.